His GBM tumor tissue demonstrated O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, wild-type isocitrate dehydrogenase 1/2 (IDH1/2) and amplification of the epidermal growth factor receptor (EGFR) gene. The gene discussed is IDH1; the disease is glioblastoma.